Ipca Laboratories LtdPharmaceuticalsINE571A01038Consolidated₹2009.60+39.30 (+1.99%)Jun-26
Valuation
Market Cap₹50.98K Cr
TTM PE38.92x
Forward PE37.22x
PEG2.63
Book Value₹317.84
P/B6.32x
TTM EPS₹51.63
Fwd EPS₹53.99
TTM Revenue₹10.13K Cr
TTM PAT₹1.38K Cr
TTM EBITDA₹2.23K Cr
TTM EBIT₹1.80K Cr
Last Qtr PAT₹424.27 Cr
Last Qtr EBITDA₹669.51 Cr
Last Qtr EBIT₹558.70 Cr
Profitability
ROE17.05%
ROCE21.37%
TTM NPM13.58%
TTM EBITDA %22.04%
Curr OPM15.08%
Last OPM12.36%
Curr NPM—
Last NPM—
Curr EPS₹15.84
Last EPS₹11.79
Balance sheet
Equity₹25.37 Cr
Reserve₹8.04K Cr
Total Debt₹749.94 Cr
D/E0.09x
Interest %2.80%
Curr Interest₹11.88 Cr
Price / range
Close₹2009.60
vs 52W High—
vs 52W Low—
MA50—
MA200—
Returns
1D+1.99%
1W+2.09%
1M+6.77%
3M+30.19%
6M+30.32%
1Y+50.19%
2Y+39.13%
3Y+116.54%
5Y+61.19%
Diwali+43.79%
Sector peers — Pharmaceuticals
Financial Results
Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS
Standalone
16 lines · 6 periodsYearly results
Last 6 financial years · YoY % vs previous FY
Consolidated
16 lines · 6 periodsYearly results
Last 6 financial years · YoY % vs previous FY
Corporate Actions
Dividends, bonus issues, and stock splits